The study result shows a correlation between participants' response to a conditioned pain modulation test and their presence of symptomatic, confirmed COVID-19 infections. Patients with covid have a high risk of developing chronic pain in old age.
Systemic inflammation, also known as myalgia, is one of the main signs of COVID-19 infection and can cause other general aches and pains. On the basis of this, a recent study headed by scientists at the University of Oklahoma demonstrates a link between symptomatic COVID-19 infections and the CNS's capacity to react to painful stimuli. The report was released on July 21, 2022, in the Journal of Pain.
There were 59 participants in the study, which was carried out from January to March 2021, and they were divided into three groups. The individuals in the symptomatic group were those who had previously experienced symptoms from COVID-19 infections that were verified by antibody test. The asymptomatic group, which included participants who were unaware they had previously been infected with COVID-19 and had not displayed any symptoms however were nonetheless identified by antibody testing, was an unanticipated addition to the study. The control group had neither been exposed to COVID-19 infection nor had any antibodies at the time of testing.
In the study case ,first,the amount of pressure required to cause a participant to report feeling pain after applying pressure to a muscle, in this example in the participant's arm or leg, was measured by the researchers for each individual. Second, the signals that are delivered from the central nervous system to the brain and spinal cord and can "alter the volume" of how much pain a person perceives were also measured by the researchers.
Further research on the relationship between COVID and pain is necessary as, if there is a probability of long-lasting abnormalities in pain modulation, this may place people at a higher risk.
